Invention Grant
- Patent Title: System and method for screening and assessing agents for tumor immunotherapy
-
Application No.: US17323078Application Date: 2021-05-18
-
Publication No.: US11965875B2Publication Date: 2024-04-23
- Inventor: Nanhai He , Youping Wang , Yang Lu , Donghui Yang
- Applicant: ADLAI NORTYE BIOPHARMA CO., LTD.
- Applicant Address: CN Hangzhou
- Assignee: ADLAI NORTYE BIOPHARMA CO. LTD.
- Current Assignee: ADLAI NORTYE BIOPHARMA CO. LTD.
- Current Assignee Address: CN Hangzhou
- Agency: Honigman LLP
- Agent Thomas A. Wootton, Esq.; Jonathan P. O'Brien
- Priority: CN 2011284771.X 2020.11.17
- Main IPC: C12N5/00
- IPC: C12N5/00 ; G01N33/50
Abstract:
The present application relates to a system and a method for effectively screening and assessing agents for tumor immunotherapy, which includes assessment for the effects of target cells, non-target cells, and tumor infiltration. The system and method of the present application can be used to comprehensively and systematically assess the effectiveness and safety of the agent against tumor immune cells.
Public/Granted literature
- US20220155282A1 SYSTEM AND METHOD FOR SCREENING AND ASSESSING AGENTS FOR TUMOR IMMUNOTHERAPY Public/Granted day:2022-05-19
Information query
